🔴 Danaher is trading 19.21% down in after-hours trading with no new clearly attributable company-specific announcement identified

Danaher is trading at $166.29, down -19.21%, after no new, clearly attributable company-specific announcement was identified for August 12, 2026.

• Earlier second-quarter concerns involved soft bioprocessing performance and cautious growth guidance; those reports date to July 21, 2026.
• Danaher’s CEO succession announcement and guidance reaffirmation were reported August 3, 2026, not August 12.
• Broader markets were modestly positive, making macro sentiment an unlikely explanation.